Harry Hixson logo

Harry Hixson

Description

He was chief executive officer from July 2004 until september 2005. Dr. Hixson served as Chief Executive Officer of Elitra Pharmaceuticals, ...

Investor Profile

Harry Hixson has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Harry Hixson frequently co-invest with?

CH
North America, New York, United States, New York
Co-Investments: 1
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 1
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 1
The Walden Group
North America, New York, United States, Tarrytown
Co-Investments: 1
Pacific Venture Group
North America, California, United States, Encino
Co-Investments: 1
U.S. Bancorp
North America, Minnesota, United States, Minneapolis
Co-Investments: 1
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 1
KG
North America, Rhode Island, United States, Providence
Co-Investments: 1
A. M. Pappas & Associates
North America, North Carolina, United States, Durham
Co-Investments: 1
Enterprise Partners
North America, California, United States, La Jolla
Co-Investments: 1

What are some of recent deals done by Harry Hixson?

Elitra Pharmaceuticals

San Diego, California, United States

Elitra Pharmaceuticals in San Diego, CA is a private company categorized under Pharmaceutical Preparations.

BiotechnologyMedicalPharmaceutical
Series UnknownOct 4, 2000
Amount Raised: $22,000,000